Introduction:
An uncommon and severe type of breast cancer is called metaplastic breast cancer. Usually, it is found as a rapidly expanding lump or tumor in the breast. The tumor frequently resembles an invasive ductal carcinoma on imaging exams, which is a type of breast cancer that originated in a milk duct and has since spread to surrounding tissue outside the channel. However, tumors associated with metaplastic breast cancer are typically larger at the time of diagnosis. Under a microscope, metaplastic breast cancer cells look like a combination of several cancer kinds. Metaplastic breast cancer is a single malignancy that may have started in very young cells and can differentiate into several kinds of adult cells.
What Is Metaplastic Breast Cancer?
The aberrant division and growth of breast cells is the initial step toward the development of breast cancer. Breast cancer comes in a variety of forms. A pathologist, a medical professional who studies tissue retrieved during a biopsy or surgery, uses a microscope to examine the cancer cells to identify the type of breast cancer that is present. About one percent of cases of breast cancer are metaplastic breast cancer, an uncommon kind of disease.
What Signs of Breast Cancer That Are Metaplastic Are Present?
Metaplastic breast cancer symptoms can include the following, as do with most other kinds of breast cancer:
-
A shift in the breast's dimensions.
-
A growth or bump in the skin.
-
Alterations to the nipple.
-
Skin that is dimpling or puckering.
-
Breast pain.
How Is a Diagnosis Made for Metaplastic Breast Cancer?
A variety of tests are used to diagnose metaplastic breast cancer. These could consist of:
-
Mammography (an X-ray imaging technique called mammography is used to look at the breast to find breast cancer and other disorders early on.
-
Ultrasonography (a core biopsy involves taking a tissue sample with a hollow needle for examination under a microscope and occasionally taking samples from lymph nodes).
-
A Fine Needle Aspiration (FNA) of the breast and occasionally the lymph nodes involves taking a sample of cells with a syringe and a fine needle so it can be examined under a microscope.
How Is Breast Cancer That Is Metaplastic Treated?
Primary Breast Cancer Surgery:
Surgery for primary breast cancer, including breast-conserving surgery, lumpectomy, or mastectomy. The treatments that are recommended for metaplastic breast cancer will be based on its characteristics, including its size, grade, hormone receptor status, and HER2 status, much as for other types of breast cancer.
Breast cancer is referred to as "triple negative" when it is HER2 negative, estrogen receptor-negative, and progesterone receptor-negative. Triple-negative metaplastic breast cancer is more common, which will also influence the course of therapy.
How Prevalent Is Triple-Negative Breast Cancer?
Breast cancer that is triple negative is more prevalent in:
-
Women with a mutated BRCA gene (especially BRCA1) in their family.
-
African American females.
-
Women who have not gone through menopause yet.
-
Ladies under 40.
Triple-negative breast cancer is more common in certain forms of primary breast cancer than in others. Among them are metaplastic and medullary breast cancers. Nonetheless, since invasive breast cancer is the most prevalent kind of breast cancer overall, the majority of patients with triple-negative breast cancer have this form of cancer.
What Is Surgery?
For metaplastic breast cancer, breast surgery is frequently the initial course of treatment. If the malignancy is triple negative, chemotherapy might be administered initially. This is referred to as the principal treatment.
The Procedure Could be:
-
Breast-conserving surgery, sometimes referred to as lumpectomy or wide local excision, involves removing the malignancy while leaving a border of healthy breast tissue surrounding it.
-
A mastectomy involves removing the entire breast, frequently including the nipple region.
-
The area of the breast that is afflicted, the extent of cancer in comparison to the size of the breast, and whether more than one part of the breast is impacted all influence how much tissue needs to be removed, and the breast surgeon will talk about this.
-
It is crucial to remove tissue from the cancer's surrounding area with a clear margin if having breast-conserving surgery. Sometimes, a second operation is required if a distinct tissue margin is not visible when the excised area is inspected under a microscope.
Removal of Lymph Nodes:
Metaplastic breast cancer is less likely to expand to the lymph nodes (glands) under the arm (axilla) than other invasive breast cancers. The medical team will seek to determine whether cancer cells are present in lymph nodes.
Biopsy of a Sentinel Lymph Node:
When testing before surgery reveals no indication that the lymph nodes contain cancer cells, sentinel lymph node biopsy is frequently performed. It assesses whether the sentinel lymph node (the first lymph node that the cancer cells are most likely to spread to) is clear of cancer cells. Multiple sentinel lymph nodes may exist. If a node is clear, it usually signifies that the others are as well, meaning no more need to be eliminated.
Chemotherapy
-
In many cases, chemotherapy will be advised for patients with metaplastic breast cancer. Chemotherapy is used to kill cancer cells with anti-cancer medications and lower the chance of breast cancer coming back or spreading.
-
The cancer's size, grade, hormone receptor, and HER2 status, as well as whether or not the lymph nodes are impacted, will all determine whether or not they are prescribed chemotherapy.
-
Chemotherapy may be given either before or after surgery.
Radiation Therapy
-
To lower the likelihood that the cancer may return to the same breast, radiation to the breast is typically administered to patients who have breast-conserving surgery.
-
Some patients might get radiation therapy to the lymph nodes located above or beneath the collarbone.
-
After a mastectomy, radiotherapy may be administered to the chest wall if certain lymph nodes under the arm are impacted, for example.
Endocrine Hormone Treatment
-
Certain breast cancers utilize the body's estrogen to fuel their growth. These are called breast cancers that are estrogen receptor-positive, or ER+.
-
The action of estrogen on breast cancer cells is blocked or stopped by hormone treatments. Drugs used in hormone therapy accomplish this in various ways.
-
Tissue from a biopsy or post-surgery is used to screen invasive breast tumors for ER+ status. The specialist will discuss the most appropriate hormone therapy if the malignancy is ER+.
Conclusion:
A rare kind of breast cancer that grows quickly and can spread to any part of the body is called metaplastic breast cancer (MpBC). Although it cannot be cured because doctors typically find it in its latter stages, medication can help patients manage their condition. Metaplastic breast cancer is an uncommon occurrence. Breast metaplastic carcinomas are notable for their clinical course variations and variability in radiology and pathology.
